| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8566968 | American Journal of Infection Control | 2018 | 6 Pages |
Abstract
NV-HAP is an underappreciated and serious patient safety issue, resulting in significant increases in cost, length of stay, and mortality. Efforts toward prevention of NV-HAP should be raised to the same level of concern as VAP prevention.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
Karen K. PhD, RN, FAAN, Dian PhD, RN, APRN-BC, Barbara MSN, RN, ACNS-BC,